Aprutumab, {a unique ADC, provides {a important breakthrough in combating cancers characterized by FGFR2 alterations. This targeted agent functions by directly targeting FGFR2, a tyrosine kinase often overexpressed in https://aprutumab461750.wikiannouncement.com/user